APMA is pleased to announce the winners of the APMA 2023 Annual Scientific Meeting Abstract Competition.
In a long-standing tradition, the last day of The National will focus on improving patient care through practice efficiency and proper coding. Sunday starts with the breakfast symposium “Role of the DPM in Value-Based Health Care” in Presidential D. Michael J. King, DPM, Chief Medical Officer, Upperline Health, and APMA past president, will discuss the evolution of health-care reimbursement models and where they are headed.
The APMA Students’ and Residents’ Program returns this year with even more helpful information for attendees who are in the early stages of their podiatric medical careers. Presented by the APMA Young Physician Leadership Panel (YPLP) and moderated by Rachel H. Albright, DPM, MPH, this program will cover a variety of relevant topics for students and residents.
“Don’t think it can’t happen to you.” That’s advice from Gene Pascarella Jr., DPM, who will reflect on the wrongful death malpractice suit he never saw coming during the Risk Management Breakfast Symposium today. Dr. Pascarella wants attendees to know they need to be prepared for the claim no physician wants to be forced to defend.
CMS issued the calendar year 2024 Medicare Physician Fee Schedule Proposed Rule and Quality Payment Program Proposed Rule on July 13. APMA is still reviewing this almost-2,000-page document.
Learn about the latest research in foot and ankle medicine and surgery at this morning’s Oral Abstracts presentations. This session is part of the APMA Abstracts Competition, and presenters are eligible for the Outstanding Oral Abstract Presentation award.
In keeping with the spirit of APMA’s continued Year of the Member focus, this year at The National we’re excited to offer meeting enhancements designed to make the on-site experience even more meaningful.
“The whole idea of antifungal resistance is relatively new; it just has come into our consciousness as providers in the last year or so,” said Warren Joseph, DPM, editor of the Journal of the American Podiatric Medical Association and presenter at this morning’s plenary lecture.
“Even the best surgeons experience complications.” So says Michelle Butterworth, DPM, track leader for this afternoon’s Track 2: Surgical Complications Panel.
It’s already July. Don’t wait for a renewal packet from your insurance carrier bearing bad news this fall. Find out now whether your practice could save with APMA’s Health-Care Solutions.
After almost a year of programming and leadership development, the current cohort of the APMA Emerging Leaders Program (ELP) will present their recommendations surrounding young physician engagement to the APMA Board of Trustees and the American Board of Foot and Ankle Surgery (ABFAS) Board of Directors at The National.
Podiatrists know the value of a multidisciplinary care team for patients with peripheral artery disease (PAD). Working closely with colleagues in vascular specialties is vital to the success of wound care and limb salvage. But the reality of finding the right treatment options for your patient may not be as clear-cut.
Back by popular demand this year are APMA’s Surgical Blitz sessions, featuring multiple, short presentations on a variety of topics, with practical advice perfect for every foot and ankle surgeon.
The National is truly the must-attend event for every podiatrist, covering the entire spectrum of foot and ankle care and representing every voice in podiatric medicine and surgery.
Most podiatric physicians know exactly how to handle a patient with heel pain, from diagnosis to treatment options. But a patient who is angry about the office running late, or one who can’t seem to follow doctor’s orders can be a significantly larger challenge.
Ross Taubman, DPM, never could have foreseen the path his career would take. “You don’t set out as a child saying, I’m going to be the president of an insurance company one day!”
In a continued effort to foster inclusivity and promote diversity within the profession, APMA invites all attendees to join us for the Diversity, Equity, and Inclusion (DEI) reception.
Aetna has informed APMA that effective July 23, it will drop its external review program regarding use of -59 Modifier when submitted with CPT 11719-11721, G0127, and 11055-11057.
As of June 27, all new DEA license applications and DEA licensure renewals will now require an attestation that the applicant has completed eight hours “on the treatment and management of patients with opioid or other substance use disorders.”
APMA submitted two comment letters to CMS on Monday, July 3, in responses to proposed changes to Medicaid generally and Medicaid Managed Care.